MARKET

ALPMF

ALPMF

Astellas Pharma
OTCPK
14.26
NaN%
Closed 09:30 05/15 EDT
OPEN
--
PREV CLOSE
14.26
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
41.25
52 WEEK LOW
14.26
MARKET CAP
25.55B
P/E (TTM)
13.91
1D
5D
1M
3M
1Y
5Y
1D
Astellas Extends Global Performance-Linked Stock Incentives for Executives
TipRanks · 1d ago
Astellas Extends Performance-Linked Stock Incentive Plan for Directors in FY2026
TipRanks · 1d ago
Astellas Rated Hold as Xtandi Headwinds Offset Pipeline Potential; Price Target Reiterated at ¥2,200
TipRanks · 4d ago
Weekly Report: what happened at ALPMF last week (0504-0508)?
Weekly Report · 5d ago
Weekly Report: what happened at ALPMF last week (0427-0501)?
Weekly Report · 05/04 09:57
Astellas Pharma (ALPMF) Gets a Hold from Citi
TipRanks · 05/01 10:37
Goldman Sachs Sticks to Its Buy Rating for Astellas Pharma (ALPMF)
TipRanks · 04/28 10:39
Weekly Report: what happened at ALPMF last week (0420-0424)?
Weekly Report · 04/27 09:58
More
About ALPMF
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Webull offers Astellas Pharma Inc stock information, including OTCPK: ALPMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPMF stock methods without spending real money on the virtual paper trading platform.